About TRAVERE THERAPEUTICS, INC.
Travere Therapeutics is a patient-centered biopharmaceutical company focused on developing life-changing therapies for rare kidney diseases. The company is committed to supporting patients, caregivers, and advocates through partnerships and community engagement.
Drug development for rare kidney diseasesClinical trials and expanded access programsPatient advocacy and community engagementTherapeutic pipeline development
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Veterans Affairs | $31K | |
| THIOLA 100 MG | Department of Veterans Affairs | $29K | |
| Federal contract award | Department of Veterans Affairs | $28K | |
| Federal contract award | Department of Veterans Affairs | $26K | |
| Federal contract award | Department of Veterans Affairs | $47K |
Is this your company?
Claim TRAVERE THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim TRAVERE THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.